Female Support
Natural health product licensed in Canada
- Other names
- Physicians Research
- Licence holder
- Natural Professional Therapeutics Inc.
- NPN or DIN-HM
- 80035537
- Status
- Active licence
- Licence date
- 19 September 2012
- Revision date
- 7 February 2025
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 100 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chrome Source : Polynicotinate de chrome (III) | 100 mcg | 100 µg |
| Valeriana officinalis Source : Racine Extraction ratio : 6:1 Dry plant equivalent : 150 mg | 25 mg | Not calculated |
| Valeriana officinalis Source : Rhizome Extraction ratio : 6:1 Dry plant equivalent : 150 mg | 25 mg | Not calculated |
| Actaea racemosa Source : Rhizome Extraction ratio : 20:1 Dry plant equivalent : 1,200 mg | 60 mg | Not calculated |
| Actaea racemosa Source : Racine Extraction ratio : 20:1 Dry plant equivalent : 1,200 mg | 60 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Eau purifiée, Hypromellose, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Female Support relieves premenstrual symptoms, and assists in the maintenance of good health. Turmeric is used in Herbal Medicine to aid digestion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen or a skin rash develops. consult a health care practitioner prior to use if you have gallstones or bile obstruction, are breast feeding, have a liver disorder or develop symptoms of liver trouble, stomach ulcers, or excess stomach acid. consult a health care practitioner if you are taking anti platelet medication, blood thinners or other prescription medications. Consumption with alcohol, other medications or natural health products with sedative properties is not recommended. Consult a health care practitioner prior to use if you are taking hormone-containing medications such as progesterone preparations. Consult a health care practitioner prior to use if you have or are pre-disposed to cancer. Discontinue use and consult a health care practitioner if you experience breast pain, discomfort and/or tenderness. Consult a health care practitioner prior to use if you are taking birth control pills. Discontinue use and consult a health care practitioner if menstruation is delayed or absent, or if you experience increased menstrual bleeding time. Consult a health care practitioner if you are taking hormone replacement therapy (HRT).
- Contre-indications
Do not take if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner. Do not expose yourself to sources of ultraviolet rays (e.g. the sun & tanning salons) for prolonged periods.
Source
Official Health Canada record, licence 80035537
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.